Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

519

Participants

Timeline

Start Date

July 13, 2020

Primary Completion Date

December 22, 2020

Study Completion Date

January 22, 2021

Conditions
Colonoscopy
Interventions
DRUG

Bowel Prep

Orally ingested liquid bowel preparation

Trial Locations (25)

10033

301 Research Site 23, New York

11023

301 Research Site 5, Great Neck

11235

301 Research Site 15, Brooklyn

27612

301 Research Site 6, Raleigh

30033

301 Research Site 2, Decatur

32127

301 Research Site 26, Port Orange

32216

301 Research Site 12, Jacksonville

33157

301 Research Site 4, Palmetto Bay

33351

301 Research Site 25, Sunrise

33709

301 Research Site 14, St. Petersburg

33756

301 Research Site 16, Clearwater

34684

301 Research Site 9, Palm Harbor

37434

301 Research Site 20, Hixson

38501

301 Research Site 18, Huntsville

39232

301 Research Site 11, Flowood

44060

301 Research Site 21, Mentor

46202

301 Research Site 10, Indianapolis

48047

301 Research Site 13, Chesterfield

53215

301 Research Site 22, Milwaukee

71105

301 Research Site 17, Shreveport

71201

301 Research Site 3, Monroe

84405

301 Research Site 1, Ogden

85351

301 Research Site 24, Sun City

89511

301 Research Site 19, Reno

92114

301 Research Site 7, San Diego

Sponsors
All Listed Sponsors
lead

Braintree Laboratories

INDUSTRY